ArticleLife (Basel, Switzerland)2023

Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer.

Fumiya Sugino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.